(Press-News.org) A study in a special early online publication of Cell, a Cell Press publication, reveals a promising new slow-release compound that protects mice against the neurodegenerative effects of both Huntington's and Alzheimer's disease. The 'prodrug' known only as JM6 works through a pathway involved in the breakdown of the amino acid tryptophan.
Surprisingly, JM6 delivers those benefits even though it doesn't cross the blood-brain barrier and therefore cannot act directly on the brain.
"Most would have assumed that the drug would have to enter the brain to have an effect," said Paul Muchowski of the University of California, San Francisco. He says the new study may therefore pave the way to new strategies for the treatment of brain diseases more broadly.
The kynurenine pathway is a major route of tryptophan breakdown. Scientists had suspected the pathway to play a role in neurodegeneration since the late 1970s, Muchowski said. Metabolites of the pathway can lead to excessive stimulation of neurons, causing damage and even death of the cells.
Muchowski's team started with a compound earlier designed to target an enzyme called kynurenine 3-monooxygenase or KMO.When KMO is inhibited, it shunts the kynurenine pathway in a direction that increases production of a neuroprotective compound known as kynurenic acid (KYNA). KYNA levels are known to decline in Huntington's and Alzheimer's brains.
But the researchers found that the starting compound (Ro 61-8048) was unstable and degraded quickly. Fortunately for Muchowski, his recently retired father Joseph Muchowski is a synthetic chemist with experience in drug development. He enlisted him in generating a slow-release prodrug version of the KMO inhibitor, which they call JM6.
They first treated mice with Huntington's disease with JM6. Chronic delivery of JM6 inhibited KMO in the animals' blood, increasing kynurenic acid levels and reducing extracellular levels of the chemical messenger glutamate in the brain. Those mice, which normally would have died by the time they were 15 weeks old, lived about 40 percent longer than they otherwise would have, Muchowski said. Their motor coordination improved and they were protected against the loss of the synapses that serve as critical junctions in the neural circuitry.
In a transgenic mouse model of Alzheimer's disease, JM6 prevented spatial memory deficits, anxiety-related behavior, and the loss of synapses. "JM6 helped the animals remember," Muchowski said.
Alzheimer's mice also become uninhibited and will run right out of the safety of the dark and into open spaces, a risky habit in the real world where predators lurk. "JM6 completely rescued that deficit."
Muchowski says the preservation of synapses they observed is especially key. That's because it's known that memory loss in Alzheimer's correlates more closely with the loss of synapses than with the loss of neurons.
Muchowski said they do plan to test the drug's use in humans through clinical trials. Since JM6 is a new compound, they will have to start with trials designed to test the safety and toxicity of the drug. He expects the first trials could be underway in about two year's time in patients with Huntington's disease.
"One way or another, we will move forward," he said.
INFORMATION: END
Thousands of events are scheduled across the nation to celebrate the joys and traditions that come with riding bicycles. While most events are geared to welcome spring and summertime activities, some, like the Bike Bonanza in downtown Salt Lake City, promote healthy living and efficiency. Another national event, the Ride of Silence, is dedicated to reminding people about bicycle safety and honoring those killed in bicycle accidents.
Each year since 2003, riders have gathered on the third Wednesday of May to bring awareness to the hazards bicyclists endure from motorists. ...
AUDIO:
University of Michigan School of Public Health researcher Stoddard's research shows a link between violent behavior and brain injury in youth.
Click here for more information.
ANN ARBOR, Mich.---Young people who have sustained a head injury during their lifetime are more likely to engage in violent behavior, according to an eight-year study from the University of Michigan School of Public Health.
Further, the research found that young people who suffered a recent ...
(SALT LAKE CITY)—Parents and health care providers can't always tell whether toddlers display signs of autism syndrome disorder (ASD), but new research from the University of Utah shows that a significant portion of at-risk children between 14-24 months can be identified through systematic screening by autism experts and providers working together.
Identifying children with ASD as young as possible is critical for the early intervention that can improve their lives and ability to function in the world. But a systematic way to do that has not been established, according ...
As the World Health Organisation suggests the E. coli outbreak in Germany is a strain never before seen in an outbreak – O104:H4 – laboratory science conducted at the University of Southampton indicates a role for copper in preventing the spread of such infections.
Professor Bill Keevil, Head of the Microbiology Group and Director of the Environmental Healthcare Unit at the University of Southampton, explains: "A study looking at copper's efficacy against new strains of E. coli has just been completed. Although it did not specifically look at O104, all the strains investigated ...
LOUISVILLE, Ky. – University of Louisville researchers are one step closer to helping millions of people whose salivary glands no longer work because of disease or damage from treatment of diseases.
The scientific finding of Douglas Darling, PhD, professor, Department of Oral Health and Rehabilitation, UofL School of Dentistry, and his team identified a protein sorting mechanism used by the salivary gland. The National Institutes of Health supported study published on-line first this week in the Journal of Dental Research.
The scientific discovery could form the ...
Scientists from the Florida campus of The Scripps Research Institute have uncovered a potentially important new therapeutic target that could prevent stress-related cell death, a characteristic of neurodegenerative diseases such as Parkinson's, as well as heart attack and stroke.
In the study, published recently in the journal ACS Chemical Biology, the scientists showed they could disrupt a specific interaction of a critical enzyme that would prevent cell death without harming other important enzyme functions.
The enzyme in question is c-jun-N-terminal kinase (JNK), ...
Wrong-site surgery is a one of the most preventable forms of medical malpractice because it is so unnecessary. It indicates sloppiness in procedure and a level of inattention to detail you would hope to never find in a surgeon or their staff.
While there are often explanations, there is never any excuse. It might be excusable in an emergency military hospital, with surgeons operating under a crush of battle injured patients, but it should simply never occur in a modern hospital.
A statement from the website of the American Academy of Orthopaedic Surgeons notes: "Wrong-site ...
The nation's system of freeing some terminally ill prisoners on grounds of compassionate release is so riddled with medical flaws and procedural barriers that many potentially medically eligible inmates are dying behind bars, say UCSF researchers in a new study.
The research, which calls for an overhaul of current practices, is published online this week in Annals of Internal Medicine.
"Current compassionate release guidelines are failing to identify seriously ill prisoners who no longer pose a threat to society, placing huge financial burdens on state budgets and contributing ...
The Fair Sentencing Act of 2010 (FSA) reduced what many have criticized as disproportionately harsh sentences for crack cocaine offenses. The sentencing ratio remains at approximately 18 to 1 for the amount of powder cocaine versus crack cocaine required to trigger the same penalty, but this is a significant reduction from a former ration of 100 to 1.
2007 Amendments
The federal sentencing guidelines were previously amended in 2007 in an effort to reduce the disparity between sentences for crack and powdered cocaine offenses. Although the sentencing guidelines were ...
PASADENA, Calif.—In many ways, life is like a computer. An organism's genome is the software that tells the cellular and molecular machinery—the hardware—what to do. But instead of electronic circuitry, life relies on biochemical circuitry—complex networks of reactions and pathways that enable organisms to function. Now, researchers at the California Institute of Technology (Caltech) have built the most complex biochemical circuit ever created from scratch, made with DNA-based devices in a test tube that are analogous to the electronic transistors on a computer chip.
Engineering ...
